Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Imagin Medical Inc C.IME

Alternate Symbol(s):  IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.


CSE:IME - Post by User

Comment by eunice12on Jul 15, 2020 12:09pm
225 Views
Post# 31271051

RE:NEWS - Imagin Medical to begin testing

RE:NEWS - Imagin Medical to begin testingAt the 8 minute mark of the stocktalk audio JH says he thinks Covid will not slow them down much because the already approved chemical will allow them to do quicker trials than other applicants. I know a biotech test company that only needs to do 300 blood samples (which is less invasive that sticking a device into someone's bladder) but they were stopped partway through tthe trial in March because the hospitals have shut down most non-Covid research until the US gets Covid under control. They don't expect to be allowed to continue the trial before the end of the year.
<< Previous
Bullboard Posts
Next >>